Federal Data HubHRSA 340B · JSON

University of Miami

Pathway to Wellness Clinic · 340B ID RWI33136A

ParticipatingRWI

University of Miami is a RWI enrolled in the federal 340B Drug Pricing Program in Miami, FL. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 26 contract-pharmacy arrangement(s) (25 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.

Contract pharmacies (26)

PharmacyLocationBeginTerminatedPharmacy ID
CAREMARK FLORIDA SPECIALTY PHARMACY LLCTAMPA, FL2024-01-0141487
CAREMARK ILLINOIS SPECIALTY PHARMACY, LLMOUNT PROSPECT, IL2024-01-0159113
CAREMARK KANSAS SPECIALTY PHARMACYLENEXA, KS2024-01-0162899
CAREMARK MASSACHUSETTS SPECIALTY PHARMACMILFORD, MA2024-01-0113653
CAREMARK MICHIGAN SPECIALTY PHARMACY, LLTROY, MI2024-01-0153118
CAREMARK NEW JERSEY SPECIALTY PHCY, LLCFAIRFIELD, NJ2024-01-0116293
CAREMARK NORTH CAROLINA SPECIALTY PHARMARALEIGH, NC2024-01-0131787
CAREMARK TENNESSEE SPECIALTY PHARMACY, LBARTLETT, TN2024-01-0145962
CAREMARK, L.L.C.REDLANDS, CA2024-01-01612
CAREMARK, L.L.C.LAS VEGAS, NV2024-01-01125644
CVS/SPECIALTY OR CARELONRX SPECIALTY PHAFLOWER MOUND, TX2024-01-01111796
CYSTIC FIBROSIS SERVICES, LLCFRISCO, TX2024-01-01110069
HOLIDAY CVS, L.L.C.MIAMI, FL2024-01-0194409
PROCARE PHARMACY DIRECT, L.L.C.MONROEVILLE, PA2024-01-012289
PROCARE PHARMACY, L.L.C.BIRMINGHAM, AL2024-01-0143566
PROCARE PHARMACY, L.L.C.MIAMI, FL2024-01-0194423
PROCARE PHARMACY, L.L.C.HONOLULU, HI2024-01-012025-06-231280
PROCARE PHARMACY, L.L.C.COLUMBIA, SC2024-01-0134053
WALGREEN CO.MIAMI, FL2024-01-019002
WALGREEN CO.MIAMI, FL2024-01-01109791
WALGREEN CO.MIAMI, FL2024-01-01110533
WALGREEN CO.MIAMI, FL2024-01-0139964
WALGREENS SPECIALTY PHARMACY, LLCCANTON, MI2024-01-014981
WALGREENS SPECIALTY PHARMACY, LLCPITTSBURGH, PA2024-01-014953
WALGREENS SPECIALTY PHARMACY, LLCFRISCO, TX2024-01-014980
Walgreens #21395Orlando, FL2024-01-01135323

Click a Pharmacy ID to see every other 340B entity using that same pharmacy.

About this data

The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.

Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.